147 related articles for article (PubMed ID: 8806091)
21. Changes in cell characteristics due to culture conditions in cell lines from human small cell lung cancer.
Terasaki T; Shimosato Y; Nakajima T; Tsumuraya M; Morinaga S; Hirohashi S; Yamaguchi K; Kato K; Ichinose H; Nagatsu T
Jpn J Clin Oncol; 1986 Sep; 16(3):203-12. PubMed ID: 3022030
[TBL] [Abstract][Full Text] [Related]
22. Advances in the biology of lung cancer. Clinical significance of neuroendocrine differentiation.
Gazdar AF
Chest; 1989 Jul; 96(1 Suppl):39S-41S. PubMed ID: 2544358
[No Abstract] [Full Text] [Related]
23. Stimulatory effect of reconstituted basement membrane components (matrigel) on the colony formation of a panel of human lung cancer cell lines in soft agar.
Yoshida S; Shimizu E; Ogura T; Takada M; Sone S
J Cancer Res Clin Oncol; 1997; 123(6):301-9. PubMed ID: 9222295
[TBL] [Abstract][Full Text] [Related]
24. Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice.
Onn A; Isobe T; Itasaka S; Wu W; O'Reilly MS; Ki Hong W; Fidler IJ; Herbst RS
Clin Cancer Res; 2003 Nov; 9(15):5532-9. PubMed ID: 14654533
[TBL] [Abstract][Full Text] [Related]
25. Comparison of features of human lung cancer cell lines and their corresponding tumors.
Wistuba II; Bryant D; Behrens C; Milchgrub S; Virmani AK; Ashfaq R; Minna JD; Gazdar AF
Clin Cancer Res; 1999 May; 5(5):991-1000. PubMed ID: 10353731
[TBL] [Abstract][Full Text] [Related]
26. Multicellular aggregates from human tumor cell lines for radiation studies.
Schwachöfer JH; Crooijmans RP; Broers JL; Hoogenhout J; Jerusalem CR; Jerusalem R; Kal HB; Mungyer G
Anticancer Res; 1989; 9(2):441-8. PubMed ID: 2546485
[TBL] [Abstract][Full Text] [Related]
27. Ability to culture resectable non-small cell lung carcinomas is correlated with recurrence.
Siegfried JM; Davis AL; Testa JR; Hunt JD; Keenan RJ; Yousem SA; Ritter PS; Ferson PF; Landreneau RJ
Ann Thorac Surg; 1994 Sep; 58(3):662-6; discussion 667. PubMed ID: 7944686
[TBL] [Abstract][Full Text] [Related]
28. Utilization of a human tumor cloning system to monitor for marrow involvement with small cell carcinoma of the lung.
Pollard EB; Tio F; Myers JW; Clark G; Coltman CA; Von Hoff DD
Cancer Res; 1981 Mar; 41(3):1015-20. PubMed ID: 6257379
[TBL] [Abstract][Full Text] [Related]
29. MRP is frequently expressed in human lung-cancer cell lines, in non-small-cell lung cancer and in normal lungs.
Giaccone G; van Ark-Otte J; Rubio GJ; Gazdar AF; Broxterman HJ; Dingemans AM; Flens MJ; Scheper RJ; Pinedo HM
Int J Cancer; 1996 Jun; 66(6):760-7. PubMed ID: 8647646
[TBL] [Abstract][Full Text] [Related]
30. Spheroid culture of primary lung cancer cells with neuregulin 1/HER3 pathway activation.
Endo H; Okami J; Okuyama H; Kumagai T; Uchida J; Kondo J; Takehara T; Nishizawa Y; Imamura F; Higashiyama M; Inoue M
J Thorac Oncol; 2013 Feb; 8(2):131-9. PubMed ID: 23328545
[TBL] [Abstract][Full Text] [Related]
31. ICAM-1 expression by lung cancer cell lines: effects of upregulation by cytokines on the interaction with LAK cells.
Melis M; Spatafora M; Melodia A; Pace E; Gjomarkaj M; Merendino AM; Bonsignore G
Eur Respir J; 1996 Sep; 9(9):1831-8. PubMed ID: 8880099
[TBL] [Abstract][Full Text] [Related]
32. Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines.
Mitsudomi T; Viallet J; Mulshine JL; Linnoila RI; Minna JD; Gazdar AF
Oncogene; 1991 Aug; 6(8):1353-62. PubMed ID: 1679529
[TBL] [Abstract][Full Text] [Related]
33. Non-small and small cell lung carcinoma cell lines exhibit cell type-specific sensitivity to edelfosine-induced cell death and different cell line-specific responses to edelfosine treatment.
Shafer SH; Williams CL
Int J Oncol; 2003 Aug; 23(2):389-400. PubMed ID: 12851688
[TBL] [Abstract][Full Text] [Related]
34. Establishment and characterization of five human small cell lung cancer cell lines from early tumor xenografts.
Arvelo F; Poupon MF; Le Chevalier T
Anticancer Res; 1994; 14(5A):1893-901. PubMed ID: 7847823
[TBL] [Abstract][Full Text] [Related]
35. Re: Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium.
Gazdar AF; Oie HK
Cancer Res; 1986 Nov; 46(11):6011-2. PubMed ID: 3019544
[No Abstract] [Full Text] [Related]
36. The serum-free establishment and in vitro growth properties of classic and variant small cell lung cancer cell lines.
Carney DN; Bepler G; Gazdar AF
Recent Results Cancer Res; 1985; 99():157-66. PubMed ID: 2999914
[No Abstract] [Full Text] [Related]
37. Biological heterogeneity of small cell lung cancer.
Carney DN; Gazdar AF; Nau M; Minna JD
Semin Oncol; 1985 Sep; 12(3):289-303. PubMed ID: 2996148
[TBL] [Abstract][Full Text] [Related]
38. The small GTPase RhoA has greater expression in small cell lung carcinoma than in non-small cell lung carcinoma and contributes to their unique morphologies.
Varker KA; Phelps SH; King MM; Williams CL
Int J Oncol; 2003 Mar; 22(3):671-81. PubMed ID: 12579323
[TBL] [Abstract][Full Text] [Related]
39. Generation and characterization of non-small-cell lung cancer cell lines and clones for use in the study of immunotherapy.
Yannelli JR
Cancer Biother Radiopharm; 2010 Jun; 25(3):269-78. PubMed ID: 20578832
[TBL] [Abstract][Full Text] [Related]
40. [Immunocytochemical characterization of malignant pleural effusions of small cell bronchial cancer].
Guzman J; Kraft A; Bross KJ; Würtemberger G; Costabel U
Pneumologie; 1990 Feb; 44 Suppl 1():601-2. PubMed ID: 2164207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
